Prostate Cancer Treatment Expert Dr. David B. Samadi, MD Responds to Cancer Institute of New Jersey Study
March 19, 2010 by Prostate Dr.
Utility And Health-Related Quality Of Life In Prostate Cancer Patients 12 Months After Radical Prostatectomy Or ... UroToday.com - The most common curative treatments for localized prostate cancer (PC), radical prostatectomy (RP) and radiation therapy (RT), have significant effects on quality of life. Most studies measured quality of life using psychometric instruments. Another approach uses the concept of utility. Utility is a global measure, scaled between 0 (dead) and 1 (full health), which reflects not ... Read more on Medical News Today
Related prostate health articles:
- Watson Pharmaceuticals’ TRELSTAR receives FDA approval for treatment of advanced prostate cancer: Multimedia software program developed to help prostate cancer patients make treatment decisions Mount Sinai School of Medicine is leading a study of patients newly-diagnosed with prostate cancer to determine if providing them with multimedia materials can help them make more informed treatment decisions. Michael Diefenbach, Ph.D., Associate Professor of Urology at Mount Sinai School of Medicine
- Changing drug therapy can help breast cancer patients get full benefit of tamoxifen treatment: New GreenLight MoJo(TM) Now Delivers 400kJ for More Efficient Laser Therapy to Treat Enlarged Prostate MINNETONKA, Minn., March 25 /PRNewswire-FirstCall/ — American Medical Systems® (AMS) (Nasdaq: AMMD), a leading provider of world-class devices and therapies for both male and female pelvic health, announced the release of GreenLight MoJo, a new software upgrade for its industry-leading GreenLight
- Prostate Treatments: Therapeutic Options Based on Cancer Stage: It is important for men to know their options when it comes to prostate treatments specific to a cancer’s stage. Staging is used to describe the extent by which a cancer has spread. In prostate cancer, the most commonly used staging system is called the TNM. The overall stage under the TNM system is expressed
- Germany’s University Medical Center Mannheim Accelerates Cancer Care with Elekta’s Monaco Planning Software: Immunovaccine Begins Patient Recruitment For Phase 1 Trial Of DPX-0907 Cancer Vaccine Immunovaccine Inc. (TSX VENTURE:IMV) announced that it has started screening patients for its Phase 1 clinical trial, investigating the company’s therapeutic cancer vaccine, DPX-0907, as a treatment for patients with advanced stage breast, ovarian and prostate cancer. The primary goal of the trial is
- Immunovaccine Begins Patient Recruitment for Phase 1 Trial of DPX-0907 Cancer Vaccine: Immunovaccine Begins Patient Recruitment for Phase 1 Trial of DPX-0907 Cancer Vaccine HALIFAX, NOVA SCOTIA– – Immunovaccine Inc. today announced that it has started screening patients for its Phase 1 clinical trial, investigating the company’s therapeutic cancer vaccine, DPX-0907, as a treatment for patients with advanced stage breast, ovarian and prostate cancer. Read more on CCNMatthews via
Comments